PAK-dependent regulation of actin dynamics in breast cancer cells

Metastatic Breast Cancer has a poor 25% survival rate and currently there are no clinical therapeutics which target metastasis. ‘Migrastatics’ are a new drug class which target migration pathway effector proteins in order to inhibit cancer cell invasion and metastasis. The p21-activated kinases (PAK...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Marianne, Gale, Madeline E., Wells, Claire M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941713/
https://www.ncbi.nlm.nih.gov/pubmed/35385780
http://dx.doi.org/10.1016/j.biocel.2022.106207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941713/
https://www.ncbi.nlm.nih.gov/pubmed/35385780
http://dx.doi.org/10.1016/j.biocel.2022.106207

Ejemplares similares